KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Shares Repurchased (2017 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Shares Repurchased for 9 consecutive years, with $53.4 million as the latest value for Q3 2025.

  • Quarterly Shares Repurchased fell 45.45% to $53.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $295.5 million through Dec 2025, up 45.14% year-over-year, with the annual reading at $295.5 million for FY2025, 45.14% up from the prior year.
  • Shares Repurchased for Q3 2025 was $53.4 million at Bio-Rad Laboratories, down from $140.2 million in the prior quarter.
  • The five-year high for Shares Repurchased was $207.4 million in Q2 2023, with the low at $4.7 million in Q1 2024.
  • Average Shares Repurchased over 5 years is $99.5 million, with a median of $99.4 million recorded in 2024.
  • The sharpest move saw Shares Repurchased plummeted 51.3% in 2024, then skyrocketed 2068.09% in 2025.
  • Over 5 years, Shares Repurchased stood at $50.0 million in 2021, then surged by 81.41% to $90.7 million in 2022, then surged by 120.48% to $200.0 million in 2023, then tumbled by 51.04% to $97.9 million in 2024, then plummeted by 45.45% to $53.4 million in 2025.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $53.4 million, $140.2 million, and $101.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.